CNIPA.AI
검색으로 돌아가기
기록

MODULATION OF THE GUT MICROBIOME TO TREAT MENTAL DISORDERS OR DISEASES OF THE CENTRAL NERVOUS SYSTEM

발명심사 중
1조회수
12청구항 · 1 독립항
§ Ⅰ

개요

발명자

Philip STRANDWITZ; Kim LEWIS

IPC 분류

A61K 35/742A61K 35/74A61K 35/745A61P 25/18A61P 25/22A61P 25/24C12N 9/2C12N 9/10C12N 9/78C12N 9/88

CPC 분류

A61K35/742A61K35/74A61K35/745A61P25/18A61P25/22A61P25/24C12N9/8C12N9/69C12N9/1096C12N9/78C12N9/88C12Y102/1019C12Y113/12001C12Y206/1082C12Y305/3011C12Y401/1015C12Y401/1017Y2A50/30

The present disclosure relates to methods of treating at least one symptom of a mental disorder or disease of the central nervous system in a subject by modulating the amount of GABA produced in the subject's gut. The present disclosure also relates to methods of culturing the bacterial strain new bacterial strains. Also disclosed are methods of identifying bacterial strains capable of producing GABA, and engineering strains to produce GABA.

원문 (중국어)

The present disclosure relates to methods of treating at least one symptom of a mental disorder or disease of the central nervous system in a subject by modulating the amount of GABA produced in the subject's gut. The present disclosure also relates to methods of culturing the bacterial strain new bacterial strains. Also disclosed are methods of identifying bacterial strains capable of producing GABA, and engineering strains to produce GABA.